March, as a month, is generally tiresome. However, one detects a rather intriguing situation unfolding. The market, you see, is exhibiting a touch of the vapors – a pullback, if you will – despite certain fundamentals remaining stubbornly… robust. A most unusual combination, and naturally, a potential opportunity for those of us with a bit of capital to deploy. These aren’t wild speculations, darling. Just companies that actually do things, grow at a respectable clip, and happen to be rather essential to modern life. Let’s have a look, shall we?
1. Axon Enterprise
Axon, or TASER as the more pedestrian amongst us know it, has rather cleverly reinvented itself. It’s no longer simply a purveyor of… persuasive devices for law enforcement. It’s an entire public safety platform, powered by artificial intelligence. Quite the transformation, wouldn’t you agree? One almost feels sorry for the villains.
Fourth-quarter revenue reached a perfectly acceptable $797 million, up 39% year over year. The full year clocked in at $2.8 billion – a most respectable growth of over 30% for the fourth consecutive year. Annual recurring revenue surpassed $1.3 billion, growing at a brisk 35%. And the future contracted bookings? A rather substantial $14.4 billion, up 43%. One begins to suspect they’re cornering the market in keeping people… compliant.
They’re aiming for $6 billion in annual revenue by 2028, with adjusted EBITDA margins of 28%. More than doubling the business in three years, you see. Their roadmap includes Axon 911, Axon Vehicle Intelligence, and – rather cleverly – an AI tool that automates police report writing. One imagines the paperwork alone was enough to drive them to innovation. The valuation is, admittedly, a touch ambitious, but the execution is… impeccable. A long-term hold, decidedly.
2. Vertiv
If you happen to operate data centers running those frightfully complicated AI models, you’ll almost certainly require power and cooling to keep them functioning. Vertiv supplies both, worldwide. And the demand curve, my dear, is practically vertical. One suspects they’re laughing all the way to the bank.
Full-year revenue reached $10.2 billion, up 28% year over year. Adjusted operating margins expanded to 20.4%. Organic orders surged 81%, and the company exited 2025 with a backlog of $15.0 billion – more than a full year of revenue. Adjusted free cash flow hit $1.89 billion, up 66%. Q4 earnings jumped 37% to $1.36 per share. Quite the performance.
They recently launched their OneCore integrated modular solutions and a Digital Twin platform for high-density AI data centers, backed by a partnership with Hut 8. And they raised $2.1 billion through bond offerings to fund expansion. Management targets 22% to 24% operating margins over the medium term. One suspects they’ll exceed it. The AI infrastructure build-out isn’t slowing down, and Vertiv is one of those rare companies that simply cannot be replaced by software. A safe, long-term hold, and a rather clever one at that.
3. TransMedics Group
TransMedics Group operates the Organ Care System, or OCS, which keeps donor organs warm and functioning during transport. A rather civilized improvement over the decades-old practice of putting them on ice, wouldn’t you say? They even run their own aviation fleet for organ transport through their National OCS Program. A touch extravagant, perhaps, but undeniably effective.
Full-year revenue hit $605.5 million, up 37%. OCS Liver now accounts for 36% of all U.S. liver transplant procedures. They performed 5,139 U.S. OCS transplants in 2025, up from 3,735 in 2024. And they manage the logistics with a fleet of 22 aircraft. One imagines the frequent flyer miles are substantial.
Operating profit reached $21.3 million in Q4, representing 13.2% of revenue. Net income for the year was $190.3 million. They’re guiding for 2026 revenue of $727 million to $757 million, representing 20% to 25% growth. They hold FDA approvals for heart and lung trials and are expanding into Italy and other European markets. A company building a monopoly in organ logistics – a market with zero viable competitors and, rather touchingly, a moral imperative driving adoption. One approves.
4. Fair Isaac
Fair Isaac, of course, is the credit score company of all credit score companies. One hears its name in commercials, on the radio, and coming out of every salesman’s mouth. The vast majority of mortgage, auto loan, and credit card decisions in America are made with the help of a FICO score. It has pricing power that borders on the… well, let’s just say it’s substantial.
Fiscal year 2025 revenue was $1.99 billion, up 15.9%. Net income hit $651.9 million with a 32.8% net profit margin. Q4 revenue was $512 million with a 45.7% operating margin. Earnings per share have grown at an average annual rate of 22.2% over the past decade. Quite a track record.
The current catalyst is FICO Score 10T, a more predictive scoring model that incorporates trended credit data. One was initially skeptical, but its adoption in the conforming mortgage market will drive incremental licensing revenue for years. FICO also runs a growing software analytics business that expands its addressable market beyond credit scoring. The stock has pulled back around 25% year to date, creating a rare entry point for a near monopoly with expanding margins. A strong buy with solid financials. One can’t ask for much more, can one?
Read More
- Gold Rate Forecast
- Securing the Agent Ecosystem: Detecting Malicious Workflow Patterns
- NEAR PREDICTION. NEAR cryptocurrency
- DOT PREDICTION. DOT cryptocurrency
- Wuthering Waves – Galbrena build and materials guide
- USD COP PREDICTION
- Silver Rate Forecast
- EUR UAH PREDICTION
- USD KRW PREDICTION
- Games That Faced Bans in Countries Over Political Themes
2026-03-08 11:03